IVX 33.3% 0.2¢ invion limited

Ann: Appendix 4C - December 2019 quarter, page-7

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 78 Posts.
    lightbulb Created with Sketch. 3
    And it's not a recent situation, it has been funded for years.Compared to previous months it seems to hold above .010 , as sell sentiment diminished influenced by the fact that whoever has followed this over the years doesn't really want to miss the human trial announcements:
    "As previously announced to the market, Invion will be commencing Phase 1b human trials of
    IVX-PDT to treat skin cancer, while Peter MacCallum Cancer Institute will be commencing
    studies using IVX-PDT for the treatment of ano-genital cancer in 2020. "

    They made progress in the past 2 years releasing positive progress with no failures every 3/6 months.So they make give us something late Q1/start Q2, or even before.
    Once they begin the human trials there will be no turning back . But by all means, I really don't want to be to positive as I'm still accumulating .

    DYOR Boys and girls!
 
watchlist Created with Sketch. Add IVX (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $13.63M
Open High Low Value Volume
0.3¢ 0.3¢ 0.2¢ $6.927K 3.338M

Buyers (Bids)

No. Vol. Price($)
46 33922116 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 7526664 44
View Market Depth
Last trade - 16.10pm 31/10/2024 (20 minute delay) ?
IVX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.